tetradecanoylphorbol acetate has been researched along with Histiocytic Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ho, YS; Hsu, PL; Hsu, SM | 1 |
| Barbey, S; Gogusev, J; Nezelof, C | 1 |
2 other study(ies) available for tetradecanoylphorbol acetate and Histiocytic Sarcoma
| Article | Year |
|---|---|
Lymphomas of true histiocytic origin. Expression of different phenotypes in so-called true histiocytic lymphoma and malignant histiocytosis.
Topics: Adolescent; Adult; Biomarkers; Biomarkers, Tumor; Child; Child, Preschool; Female; Gene Rearrangement; Gene Rearrangement, beta-Chain T-Cell Antigen Receptor; Histiocytes; Histiocytic Sarcoma; Humans; Immunoglobulins; Immunohistochemistry; Infant; Lymphoma; Lymphoma, Large B-Cell, Diffuse; Male; Phenotype; Tetradecanoylphorbol Acetate; Transcription, Genetic | 1991 |
Human malignant histiocytosis CD30+ DEL cell line differentiates into macrophage-like cells when treated with a phorbol diester.
Topics: Cell Differentiation; Gene Expression Regulation, Neoplastic; Histiocytic Sarcoma; Humans; Macrophages; Phagocytosis; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 1991 |